Bortezomib with Thalidomide or with Prednisone as Maintenance Therapy for Elderly Patients with MM: The GEM20005MAS65 Trial


Bortezomib with Thalidomide or with Prednisone as Maintenance Therapy for Elderly Patients with MM: The GEM20005MAS65 Trial
Slides from a presentation at ASH 2011 and transcribed comments from a recent interview with Paul G Richardson, MD (1/24/12)

Mateos MV et al. Maintenance therapy with bortezomib plus thalidomide (VT) or bortezomib plus prednisone (VP) in elderly myeloma patients included in the GEM2005MAS65 Spanish randomized trial. Proc ASH 2011;Abstract 477.

Dr Richardson is Associate Professor of Medicine at Harvard Medical School and Clinical Director of the Jerome Lipper Center for Multiple Myeloma at Dana-Farber Cancer Institute in Boston, Massachusetts.